MYC and breast cancer: Reduced expression of active β-catenin and its downstream target gene c-MYC were detected in DACT1-expressing MB231 cells (Figure 5), suggesting that DACT1 antagonizes Wnt/β-catenin signaling by decreasing active β-catenin levels in breast cancer.